Adenocarcinoma — Trials

Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9,697 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,751
Recruiting: 1,519
Ph III recruiting: 167
Growth YoY: +8.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,318)

clinicaltrialsPublishedShowing 51–100 of 3,984 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06369610	Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer	active not recruiting	Phase 2	110	Mayo ClinicOTHER	1	Sep 25, 2026	clinicaltrials
NCT06428409	A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)	recruiting	Phase 1 / Phase 2	220	Merck Sharp & Dohme LLCINDUSTRY	13	Sep 25, 2026	clinicaltrials